Bioxytran, Inc. (OTCMKTS:BIXT) Short Interest Update

Bioxytran, Inc. (OTCMKTS:BIXT) saw a significant increase in short interest in the month of January. As of January 30th, there was short interest totaling 5,695 shares, an increase of 1,798.3% from the January 15th total of 300 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 541,049 shares, the short-interest ratio is presently 0.0 days. Based on an average daily trading volume, of 541,049 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the company are sold short.

Bioxytran Price Performance

Shares of OTCMKTS BIXT opened at $0.05 on Thursday. The stock has a fifty day moving average price of $0.07 and a 200 day moving average price of $0.07. Bioxytran has a 1-year low of $0.03 and a 1-year high of $0.23. The company has a market cap of $5.56 million, a PE ratio of -1.65 and a beta of 1.99.

About Bioxytran

Bioxytran, Inc is a clinical-stage biotechnology company focused on the development of synthetic oxygen carriers and novel oxygen therapeutics for acute care and chronic disease applications. The company’s proprietary platform is designed to safely deliver therapeutic levels of oxygen to hypoxic tissues, addressing conditions such as ischemia-reperfusion injury, organ transplantation, and traumatic injury. Its lead product candidates target unmet medical needs in cardiovascular and neurological disorders, wound healing, and critical care settings.

Bioxytran’s research pipeline comprises multiple preclinical-stage assets that leverage stabilized perfluorocarbon emulsions to achieve controlled oxygen release.